Investors should maintain a bullish stance on semiconductor leader Micron Technology (MU), targeting upside price levels between $1,050 and $1,100. Capitalize on the AI infrastructure expansion by purchasing Bloom Energy (BE) to capture data center power demand, while accumulating shares of Meta Platforms (META) on any market pullbacks. Look for short opportunities in IonQ (IONQ) following speculative rallies toward $39 that lack fundamental revenue support. Consider short positions or underweight allocations in Pfizer (PFE) and Nebius Group (NBIS) due to weak pharmaceutical pipelines and uncompetitive cloud pricing moves. Finally, immediately exit or avoid common shares of QCLS (QCLS) to protect capital from severe dilution risks tied to predatory warrants.

QCLS (QCLS)

• The equity structure is heavily impaired by preferred shares and warrants, leaving common shares at risk of extreme dilution and loss of value
  • Management and warrant holders refused to restructure or eliminate toxic warrants, leading to management departures
  • Predatory structured finance terms can allow preferred and warrant holders to convert at highly unfavorable rates for common shareholders

Takeaways

• Avoid or exit common shares: The capital structure poses extreme downside risk to common equity holders regardless of business developments

Nebius Group (NBIS)

• Heavily targeted as a short opportunity following its announcement of cloud pricing increases
  • The price hike was viewed as late to the market and ineffective against established competitors
  • Experienced significant downward price pressure and high trading volume during the session

Takeaways

• Bearish outlook: The stock faces selling pressure as recent pricing moves fail to impress the market; viable candidate for short exposure

Micron Technology (MU)

• Showing strong bullish momentum alongside the broader semiconductor sector
  • Traded aggressively higher through $960, $970, and $980
  • Potential price levels discussed between $1,050 and $1,100, with extreme upside cases cited even higher
  • The broader semiconductor rally continues to display resilient strength

Takeaways

• Bullish momentum: Favor long positions over shorting strong semiconductor leaders; target upside near the $1,050–$1,100 range

IonQ (IONQ)

• Targeted as an aggressive short candidate after spiking toward $39
  • Company press releases regarding incremental 15% quantum improvements were viewed as promotional and unconvincing
  • Labeled as overvalued and driven by speculative quantum hype rather than viable near-term fundamentals

Takeaways

• Bearish / Short opportunity: Look for short entry points on speculative rallies that lack fundamental revenue backing

CoreWeave

• Experiencing sharp declines, falling toward the $80 level
  • Concerns highlighted around sudden market offerings (ATM) and weakening secondary pricing dynamics
  • Management narratives have conflicted with recent price action, leading to caution

Takeaways

• Exercise caution: High volatility and aggressive capital-raising activities create heightened risk for secondary and private market investors

Pfizer (PFE)

• Identified as a primary short position in the healthcare sector
  • Described as facing one of the most unfavorable outlooks and weakest growth pipelines across large-cap biopharma

Takeaways

• Bearish outlook: Underweight or short candidate due to weak long-term fundamental positioning relative to peers

Meta Platforms (META)

• Viewed favorably as a core long position among mega-cap tech companies
  • Dips in the stock are viewed as attractive buying opportunities

Takeaways

• Bullish stance: Accumulate shares on market pullbacks

Bloom Energy (BE)

• Held as a long position benefiting from the AI infrastructure boom
  • Provides fuel cells and power solutions essential for energy-constrained AI data centers

Takeaways

• Bullish theme: Strong derivative play on the AI data center expansion and associated grid power shortages

Abivax (ABVX)

• Re-entered as a speculative long position in the clinical biotech space
  • Acknowledged as a high-volatility stock with sharp historical price swings

Takeaways

• Speculative Buy: High-risk, high-reward biotech play suitable only for risk-tolerant portfolios

Twist Bioscience (TWST)

• Evaluated as a potential contrarian short, though noted as difficult to fight due to strong upward momentum
  • Emphasized the risk of fighting strong momentum stocks without clear technical breakdown signals

Takeaways

• High-risk Short: Monitor for exhaustion before shorting; avoid aggressively fading strong upward momentum without confirmation